Humatrope by Lilly is a recombinant human growth hormone (HGH) medicine containing somatropin, a laboratory-produced form of human growth hormone with the same amino-acid sequence as naturally occurring HGH. Humatrope was first approved in 1987 for growth hormone-related medical treatment. This Lilly HGH is supplied as an injectable pharmaceutical product and is designed for prescribed growth-hor...
Humatrope is a recombinant human growth hormone product developed by Lilly. Its active ingredient, somatropin, is a 191-amino-acid polypeptide corresponding to naturally occurring human growth hormone.
Growth hormone plays an important role in normal growth and metabolism. Its actions include effects on IGF-1 production, protein metabolism, lipid metabolism, bone development and body composition.
Humatrope is primarily a prescription medicine used for specific forms of growth hormone deficiency and certain approved growth disorders. At Eroid, Humatrope sits within a wider HGH range featuring products from multiple established pharmaceutical brands.
After administration, somatropin binds to growth-hormone receptors throughout the body. One important downstream response occurs in the liver, where growth-hormone signalling increases production of insulin-like growth factor 1 (IGF-1).
Growth hormone and IGF-1 together influence several biological processes. These include protein synthesis, cellular growth, skeletal development and the regulation of how the body uses proteins, carbohydrates and fats.
In people with medically diagnosed growth hormone deficiency, replacing deficient HGH helps restore growth-hormone signalling toward appropriate physiological levels. In children with qualifying growth disorders, this pathway can support linear growth and skeletal development. In adults with diagnosed growth hormone deficiency, replacement treatment can influence body composition and metabolic function.
For appropriately diagnosed patients, Humatrope somatropin provides recombinant growth hormone designed to replace or supplement inadequate endogenous HGH.
Key characteristics include:
At Eroid, product identity, packaging details and relevant product information are checked as part of our product-handling process before products are offered for sale. We focus on providing customers with clearly identified products and transparent specifications.
For Humatrope Lilly, important verification characteristics include:
Brand: Lilly
Product: Humatrope
Active substance: Somatropin
Product class: Recombinant human growth hormone (HGH)
Presentation: Injectable pharmaceutical product
Category: Human Growth Hormone (HGH)
SKU: S1028
For pharmaceutical biological products such as recombinant somatropin, quality assessment can include characteristics such as active-substance identity, concentration, purity and biological activity. Where batch-specific analytical documentation is displayed, the reported values should correspond to that particular batch rather than being presented as generic results.
No reviews yet for this product.
Eroid offers UK shipping and international delivery to eligible destinations worldwide, giving customers access to products from multiple brands and categories.
Orders are handled with attention to:
Because Humatrope is a somatropin biological medicine, customers should pay particular attention to the storage and temperature requirements stated on the specific product packaging and accompanying manufacturer information once received.